Oxford Biomedica PLC — Director's Dealing 2017

Sep 5, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8627P

Oxford Biomedica PLC

05 September 2017

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

1	Issuer	Oxford BioMedica PLC
2	Reason for notification	Notification relates to DTR 3.1.2R
3	Name of PDMR	Martin Diggle
4	Connected person	Notification relates to following connected persons: Vulpes Testudo Fund
5	Notification in respect of	Notification in respect of holdings of persons in 4 above
6	Description of shares	Oxford BioMedica PLC ordinary shares of 1p each
7	Name of registered shareholders and number of shares	Vulpes Life Sciences Fund - 549,932,000 shares Vulpes Testudo Fund - 33,334,434 shares
8	Nature of transaction	Disposal
9	Number of shares acquired	N/A
10	Percentage of issued class acquired	N/A
11	Shares disposed	Vulpes Testudo Fund - 2,377,600
12	Percentage of issued class disposed	Vulpes Testudo Fund - 0.08%
13/14	Price per share of transactions, and date	Vulpes Testudo Fund Sold     2,377,600 shares @ £0.1009, 31 Aug 2017
15	Total holding following notification and total percentage holding following notification	Vulpes Life Sciences Fund - 549,932,000 shares 17.7% Vulpes Testudo Fund - 30,956,834 shares 1.0%
16	Date issuer informed	05 Sept 2017
23	Any additional information	None
24	Contact name and telephone number	S. Paynter, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBGGDCBSGBGRU